INCISIVE Implementation Guide
0.1.1 - draft

INCISIVE Implementation Guide - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

ConceptMap: Tumor profile result model of Lung cancer to the FHIR Profile map (Experimental)

Official URL: https://fhir.incisive-project.eu/ConceptMap/LungTumorProfileResultConceptMap Version: 0.1.1
Draft as of 2024-03-19 Computable Name: LungTumorProfileResultConceptMap

Tumor profile result model of Lung cancer to the FHIR Profile map

It shows how the tumor profile result model of Lung cancer is mapped into the FHIR Profile/structureDefinition

Mapping from Tumor profile result Lung to Observation for Lung cancer

DRAFT (not intended for production usage). Published on 2024-03-19 13:26:22+0100 by INCISIVE (INCISIVE: https://incisive-project.eu/, fhir@incisive-project.eu).

Tumor profile result model of Lung cancer to the FHIR Profile map


Group 1Mapping from Tumor profile result Lung to Observation for Lung cancer

Source CodeRelationshipTarget Code
LungTumorProfileResultLogicalModel.tumorProfileResultID (An identifier for the tumor profile result)is related toObservation.id
LungTumorProfileResultLogicalModel.patientID (INCISIVE patient)is equivalent toObservation.subject.reference
LungTumorProfileResultLogicalModel.pdl1 (PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.kras (KRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.pik3ca (PIK3CA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.erbb2 (ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.igf1r (Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.ros1 (Chromosome region 6q22 rearrangements in Tissue by FISH)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.ret (RET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.met (MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.her2 (HER2 Ag [Presence] in Tissue by Immune stain)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.egfr (EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueQuantity
LungTumorProfileResultLogicalModel.alk (ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean
LungTumorProfileResultLogicalModel.braf (BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal)is related toObservation.component.valueBoolean

INCISIVE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952179. However, the content of this website reflects the opinion of its authors and does not in any way represent opinions of the European Union. European Commission is not responsible for any use that may be made of the information the website contains.
https://ec.europa.eu/digital-single-market/en/policies/ehealth